Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in Active Surveillance for Prostate Cancer
NCT01733836Phase 2Withdrawn
- Sponsor
- University Health Network
- Start
- Jan 2013
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of metformin in prostate cancer (PCa), sponsored by University Health Network. Planned start Jan 2013; status: withdrawn.
02
Drugs
metformin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01733836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01733836.